Strategy built around two complementary development axes: GMP Individualized Phage Therapies (IPT) and Phage Therapies Medicinal Products (PTMP), to maximize access to phage therapy care Acceleration ...
NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (OVID) (Nasdaq: OVID), a biopharmaceutical company developing small molecule medicines for brain disorders with significant unmet ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する